跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,957 条关于
“parainfluenza virus”
全部
8,957
临床试验
5,875
药物
1,119
机构
33
资讯
1,930
去年
Vicebio Secures $100 Million to Advance RSV and hMPV Combination Vaccine
2年前
RSV Vaccine Development Surges with New Approvals and Diverse Strategies
去年
Blue Lake and CyanVac Report Promising Phase 1 Results for Intranasal COVID-19 Vaccine CVXGA
3年前
Blue Lake Biotechnology's Nasal COVID-19 Vaccine Shows 86% Efficacy in Phase 1 Trial
11个月前
Clover Biopharmaceuticals Reports Positive Phase I Data for First-in-Class RSV-hMPV-PIV3 Combination Vaccines
去年
Blue Lake and CyanVac Present Promising Intranasal Vaccine Data at ISV Annual Congress
去年
Blue Lake and CyanVac's Intranasal COVID-19 Vaccine Shows Promise in Phase 2a Trial
去年
CyanVac's Intranasal COVID-19 Vaccine Candidate, CVXGA, Enters Phase 2b Trial
去年
Blue Lake Biotech's Intranasal RSV Vaccine Shows Promise in Pediatric Trial
上个月
Hidden Army of Tissue-Resident Memory T Cells Defends Human Lungs Against a Broad Range of Pathogens
第 1 页,共 193 页
上一页
下一页